EPISODE · Mar 7, 2022 · 12 MIN
Greater Cancer Risk Linked to Certain Oral DMTs & Supplements for MS
from MS News & Perspectives · host MS News Today
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how S1P receptor modulators such as Mayzent and Gilenya may be associated with a greater likelihood of skin cancer. He also reads “The Supplements of Mice and Men”, from John Connor's regular column "Fall Down, Get Up Again".=================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/
NOW PLAYING
Greater Cancer Risk Linked to Certain Oral DMTs & Supplements for MS
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m